164 related articles for article (PubMed ID: 30577764)
1. Evaluation of the quality and value of data sources for postmarket surveillance of the safety of cough and cold medications in children.
Green JL; Reynolds KM; Banner W; Bond GR; Kauffman RE; Palmer RB; Paul IM; Dart RC
BMC Med Res Methodol; 2018 Dec; 18(1):175. PubMed ID: 30577764
[TBL] [Abstract][Full Text] [Related]
2. Adverse reactions to over-the-counter cough and cold products among children: the cases managed out of hospitals.
Vassilev ZP; Chu AF; Ruck B; Adams EH; Marcus SM
J Clin Pharm Ther; 2009 Jun; 34(3):313-8. PubMed ID: 19646077
[TBL] [Abstract][Full Text] [Related]
3. Pediatric fatalities associated with over the counter (nonprescription) cough and cold medications.
Dart RC; Paul IM; Bond GR; Winston DC; Manoguerra AS; Palmer RB; Kauffman RE; Banner W; Green JL; Rumack BH
Ann Emerg Med; 2009 Apr; 53(4):411-7. PubMed ID: 19101060
[TBL] [Abstract][Full Text] [Related]
4. Antihistamine-containing cough/cold medications present a low hazard in pediatric accidental exposure incidents: analysis of Poison Control Center data.
Skare JA; Abeln SB
Vet Hum Toxicol; 1997 Dec; 39(6):367-71. PubMed ID: 9397509
[TBL] [Abstract][Full Text] [Related]
5. Medication Errors From Over-the-Counter Cough and Cold Medications in Children.
Wang GS; Reynolds KM; Banner W; Bond GR; Kauffman RE; Palmer RB; Paul IM; Rapp-Olsson M; Green JL; Dart RC
Acad Pediatr; 2020 Apr; 20(3):327-332. PubMed ID: 31562931
[TBL] [Abstract][Full Text] [Related]
6. Relating calls to US poison centers for potential exposures to medications to Centers for Disease Control and Prevention reporting of influenza-like illness.
Beauchamp GA; McKeown NJ; Rodriguez S; Spyker DA
Clin Toxicol (Phila); 2016 Mar; 54(3):235-40. PubMed ID: 26818907
[TBL] [Abstract][Full Text] [Related]
7. Adverse events associated with diphenhydramine in children, 2008-2015.
Palmer RB; Reynolds KM; Banner W; Bond GR; Kauffman RE; Paul IM; Green JL; Dart RC
Clin Toxicol (Phila); 2020 Feb; 58(2):99-106. PubMed ID: 31062642
[No Abstract] [Full Text] [Related]
8. Impact of the voluntary withdrawal of over-the-counter cough and cold medications on pediatric ingestions reported to poison centers.
Klein-Schwartz W; Sorkin JD; Doyon S
Pharmacoepidemiol Drug Saf; 2010 Aug; 19(8):819-24. PubMed ID: 20533537
[TBL] [Abstract][Full Text] [Related]
9. Effect of cough and cold medication restriction and label changes on pediatric ingestions reported to United States poison centers.
Mazer-Amirshahi M; Reid N; van den Anker J; Litovitz T
J Pediatr; 2013 Nov; 163(5):1372-6. PubMed ID: 23769500
[TBL] [Abstract][Full Text] [Related]
10. Analysis of completeness for spontaneous reporting of disease-modifying therapies in multiple sclerosis.
Araujo AGS; Lucchetta RC; Tonin FS; Pontarolo R; Borba HHL; Wiens A
Expert Opin Drug Saf; 2021 Jun; 20(6):735-740. PubMed ID: 33641547
[No Abstract] [Full Text] [Related]
11. Trends in adverse events and related health-care facility utilization from cough and cold medication exposures in children.
Wang GS; Green JL; Reynolds KM; Banner W; Bond GR; Kauffman RE; Palmer RB; Paul IM; Rapp-Olsson M; Dart RC
Clin Toxicol (Phila); 2021 Apr; 59(4):351-354. PubMed ID: 32914676
[TBL] [Abstract][Full Text] [Related]
12. Revisiting the safety of over-the-counter cough and cold medications in the pediatric population.
Yang M; So TY
Clin Pediatr (Phila); 2014 Apr; 53(4):326-30. PubMed ID: 24198312
[TBL] [Abstract][Full Text] [Related]
13. Cough and cold medication use by US children, 1999-2006: results from the slone survey.
Vernacchio L; Kelly JP; Kaufman DW; Mitchell AA
Pediatrics; 2008 Aug; 122(2):e323-9. PubMed ID: 18676518
[TBL] [Abstract][Full Text] [Related]
14. Adverse events associated with pediatric exposures to dextromethorphan.
Paul IM; Reynolds KM; Kauffman RE; Banner W; Bond GR; Palmer RB; Burnham RI; Green JL
Clin Toxicol (Phila); 2017 Jan; 55(1):25-32. PubMed ID: 27736263
[TBL] [Abstract][Full Text] [Related]
15. Adverse Events to Food Supplements Containing Red Yeast Rice: Comparative Analysis of FAERS and CAERS Reporting Systems.
Raschi E; Girardi A; Poluzzi E; Forcesi E; Menniti-Ippolito F; Mazzanti G; De Ponti F
Drug Saf; 2018 Aug; 41(8):745-752. PubMed ID: 29582393
[TBL] [Abstract][Full Text] [Related]
16. Adverse events from cough and cold medications in children.
Schaefer MK; Shehab N; Cohen AL; Budnitz DS
Pediatrics; 2008 Apr; 121(4):783-7. PubMed ID: 18227192
[TBL] [Abstract][Full Text] [Related]
17. Safety Profile of Cough and Cold Medication Use in Pediatrics.
Green JL; Wang GS; Reynolds KM; Banner W; Bond GR; Kauffman RE; Palmer RB; Paul IM; Dart RC
Pediatrics; 2017 Jun; 139(6):. PubMed ID: 28562262
[TBL] [Abstract][Full Text] [Related]
18. Caffeinated energy drinks: adverse event reports to the US Food and Drug Administration and the National Poison Data System, 2008 to 2015.
Markon AO; Jones OE; Punzalan CM; Lurie P; Wolpert B
Public Health Nutr; 2019 Oct; 22(14):2531-2542. PubMed ID: 31317857
[TBL] [Abstract][Full Text] [Related]
19. Adverse drug and device reactions in the oral cavity: surveillance and reporting.
Zavras AI; Rosenberg GE; Danielson JD; Cartsos VM
J Am Dent Assoc; 2013 Sep; 144(9):1014-21. PubMed ID: 23989840
[TBL] [Abstract][Full Text] [Related]
20. Mandatory labeling requirements and over-the-counter cough and cold medication use in early childhood.
DeGroot J; Anderson LN; Chen Y; Birken CS; Parkin PC; Carsley S; Khovratovich M; Mamdani M; Maguire JL;
Can J Public Health; 2016 Mar; 106(8):e477-82. PubMed ID: 26986907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
